Oculax0.2%+0.36%+1%

Oculax is an ophthalmic lubricant (artificial tears) combination indicated for:

• Established/OTC-monograph use: Temporary relief of burning, irritation, and discomfort due to dryness of the eye.
• Established/OTC-monograph use: Relief of ocular discomfort caused by minor irritants such as wind, sun exposure, air conditioning, prolonged screen use, or reduced blinking.
• Protective/adjunct use: As a protectant against further irritation, or to promote comfort when the eye is exposed to dry or irritant conditions.
• Adjunct use: Supportive lubrication in contact lens wearers experiencing dryness (only with lens-compatible formulations; see Precautions).

This is a symptomatic, supportive therapy; it does not treat the underlying cause of dry eye disease and does not replace evaluation for persistent or worsening symptoms.

Each mL of ophthalmic solution contains Glycerol (glycerin), Hypromellose (hydroxypropyl methylcellulose), and Polyethylene Glycol 400 as the active demulcent/lubricating ingredients, in an isotonic buffered aqueous vehicle, with or without a preservative depending on the specific product presentation (single-dose preservative-free units are available for frequent use or sensitive eyes).

Oculax is a fixed-dose combination ophthalmic lubricant used as artificial tears. Glycerol is a humectant demulcent, Hypromellose is a viscosity-increasing cellulose polymer, and Polyethylene Glycol 400 is a water-soluble demulcent polymer; together they form a stable, viscous tear-film substitute that coats the ocular surface, reduces friction between the eyelid and cornea, and slows evaporative tear loss.

It is classified as an over-the-counter (OTC) ophthalmic demulcent product used for the symptomatic management of dry eye and minor ocular irritation.

Ophthalmic lubricant / demulcent (artificial tears); Oculax belongs to the class of ocular surface lubricants used for dry eye and irritation relief.

Glycerol + Hypromellose + Polyethylene Glycol 400 acts locally on the ocular surface with no intended systemic pharmacologic action.

• Glycerol is a small humectant molecule that helps retain moisture at the ocular surface and contributes to the osmotic balance of the tear film.
• Hypromellose is a semi-synthetic cellulose derivative that increases the viscosity of the tear film, prolonging ocular surface contact time and reducing friction during blinking.
• Polyethylene Glycol 400 is a water-soluble polymer that acts as a demulcent, coating the cornea and conjunctiva to form a smooth, lubricating film that reduces evaporative water loss.

Together, these agents stabilize the pre-corneal tear film, reduce surface friction and desiccation, and provide symptomatic relief without significant systemic absorption when used as directed.

For ophthalmic (topical eye) use only. Wash hands before use. Instill directly into the conjunctival sac of the affected eye(s). Do not inject or take by any other route. If using other eye drops or ointments concurrently, space administration by at least 5-10 minutes and use this product last if an ointment is involved.

Oculax has minimal potential for clinically significant drug interactions due to negligible systemic absorption.

• Other topical ophthalmic medications: When used together with other eye drops (e.g., anti-glaucoma agents, antibiotics, antihistamines), simultaneous instillation can dilute or wash out the other medication. Space doses at least 5-10 minutes apart, and instill this lubricant last if a viscous drop or ointment is also being used.
• Preservative-containing formulations: Frequent concurrent use of multiple preserved eye drops may increase the risk of ocular surface irritation; preservative-free single-dose units are preferred for frequent dosing or concurrent multi-drop regimens.

Oculax is generally very well tolerated, as it is minimally to not systemically absorbed. Reported effects are typically local and transient:

• Temporary blurred vision immediately after instillation
• Mild stinging, burning, or a foreign-body sensation on application
• Ocular discomfort, itching, or redness
• Eyelid crusting or matting (with some formulations)

If eye pain, marked redness, vision changes, or discomfort persists beyond 72 hours or worsens, discontinue use and seek medical advice (see Precautions).

There are no well-controlled studies specifically evaluating Oculax in pregnancy or lactation. Because ocular administration results in minimal to negligible systemic absorption, the risk to a fetus or breastfeeding infant is expected to be very low; however, as a general precaution, pregnant or breastfeeding women should use this product only if clearly needed and should consult a physician or pharmacist before use.

Observe the following precautions when using Oculax:

• Contact lenses: Remove contact lenses before instillation unless the specific product is labeled as safe for use with lenses in place; wait as directed on the label before reinserting lenses.
• Duration of symptoms: Discontinue use and consult a physician if eye pain, changes in vision, or redness of the eye worsens or persists beyond 72 hours.
• Contamination avoidance: Do not touch the dropper tip to the eye, eyelid, fingers, or any other surface, to avoid contaminating the solution.
• Product sharing: Do not share the bottle with another person, as this may spread eye infections.
• Discard after opening: Follow the product label for the maximum period of use after opening (typically 4-6 weeks for multidose bottles); preservative-free single-dose units should be discarded after a single use.
• Not for injection or oral use: For topical ophthalmic use only.

Ocular overdose (excessive instillation) of Oculax is unlikely to cause serious harm and may cause transient blurred vision or watering of the eye; simply blot away the excess. If the product is accidentally swallowed in significant quantity, or if a severe or unexpected reaction occurs, seek immediate medical attention or contact a poison control center/emergency services rather than attempting home treatment.

Store at room temperature (below 30°C), away from light and moisture. Keep out of reach of children. Discard the bottle after the period stated on the label following first opening (do not use beyond the labeled in-use period), and discard single-dose preservative-free units immediately after use.

Contact lens wearers: Remove lenses before use unless the product is specifically labeled as lens-compatible; see Precautions.

Elderly: No special dose adjustment is required; age-related dry eye is a common indication for use.

Renal or hepatic impairment: No dose adjustment is necessary, as systemic absorption of Oculax is negligible with ocular use.

Pregnancy and lactation: See Pregnancy and Lactation section above.

May be used as needed for symptomatic relief of dry eye and ocular irritation, including on a long-term, as-needed basis for chronic dry eye. If symptoms do not improve, or if eye pain, vision changes, or redness persist beyond 72 hours or worsen at any time, discontinue use and consult a physician.

Ophthalmic demulcent / lubricant (artificial tears) combination.

Glycerol + Hypromellose + Polyethylene Glycol 400 works by combining a humectant (glycerol), a viscosity-enhancing polymer (hypromellose), and a water-soluble demulcent (polyethylene glycol 400) to form a stable, lubricating film over the ocular surface. This film reduces friction from blinking, slows evaporation of the natural tear film, and helps retain moisture, thereby relieving the burning, irritation, and foreign-body sensation associated with dry eye.

Ophthalmic lubricants such as Oculax are commonly used in children for dry eye or ocular irritation under adult supervision; however, formal safety and efficacy data in young children (particularly infants) are limited, and formal age-based labeling varies by product. Use in children, especially those under 2 years of age, should be under the guidance of a physician. Follow the same instillation technique as for adults and avoid contamination of the dropper tip.